MCID: TYP024
MIFTS: 41

Type Ii Mixed Cryoglobulinemia malady

Genetic diseases, Neuronal diseases, Cardiovascular diseases, Nephrological diseases, Respiratory diseases, Bone diseases, Rare diseases, Immune diseases categories

Aliases & Classifications for Type Ii Mixed Cryoglobulinemia

About this section
Sources:
47Orphanet, 26ICD10 via Orphanet
See all sources

Summaries for Type Ii Mixed Cryoglobulinemia

About this section


MalaCards based summary: Type Ii Mixed Cryoglobulinemia, also known as mc type ii, is related to cryoglobulinemia and hepatitis. An important gene associated with Type Ii Mixed Cryoglobulinemia is CD5 (CD5 molecule), and among its related pathways are Calcineurin-regulated NFAT-dependent transcription in lymphocytes and Immune response Role of integrins in NK cells cytotoxicity. The compounds amoxicillin and bosentan have been mentioned in the context of this disorder. Affiliated tissues include bone, b cells and lymph node, and related mouse phenotypes are normal and renal/urinary system.

Related Diseases for Type Ii Mixed Cryoglobulinemia

About this section

Diseases in the Cryoglobulinemia, Familial Mixed family:

Mixed Cryoglobulinemia Type Iii type ii mixed cryoglobulinemia

Diseases related to Type Ii Mixed Cryoglobulinemia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 74)
idRelated DiseaseScoreTop Affiliating Genes
1cryoglobulinemia32.1CD5, CD40LG
2hepatitis31.1FAS, FASLG, HLA-DRB1
3hepatitis c30.9CD40LG, HLA-DRB1, FAS
4vasculitis30.8CD40LG, FN1
5hepatitis c virus10.8
6macroglobulinemia10.5CD5
7b-cell lymphomas10.4
8glomerulonephritis10.4
9narcolepsy10.3HLA-DRB1
10hiv-110.3
11hodgkin lymphoma10.3
12liver disease10.3
13membranoproliferative glomerulonephritis10.3
14pyoderma gangrenosum10.3
15retinal vasculitis10.3
16hepatitis e10.3
17cerebritis10.3
18proliferative glomerulonephritis10.3
19neuropathy10.3
20pyoderma10.3
21retinitis10.3
22scleritis10.3
23indolent b cell lymphoma10.3
24lupus erythematosus10.3CD40LG
25cryoglobulinemia, familial mixed10.3CD5, CD40LG
26immunoglobulin alpha deficiency10.2HLA-DQB1, CD40LG
27pregnancy loss, recurrent 110.2HLA-DQB1, CD40LG
28leptospirosis10.2CD40LG, FN1
29juvenile rheumatoid arthritis10.2HLA-DQB1, HLA-DRB1
30pulmonary tuberculosis10.1HLA-DRB1, HLA-DQB1
31thyroiditis10.1HLA-DRB1, FASLG
32diabetes mellitus, insulin-dependent10.1FASLG, HLA-DRB1
33hepatitis b10.1HLA-DRB1, HLA-DQB1
34lupus nephritis10.1FN1, CD40LG
35skin disease10.1HLA-DRB1, FN1
36silicosis10.1FASLG, FAS
37lymphomatoid papulosis10.1FASLG, FAS
38hypersensitivity syndrome, carbamazepine-induced10.1FASLG, FAS
39autoimmune lymphoproliferative syndrome10.1FASLG, FAS
40iga glomerulonephritis10.1CD40LG, FN1
41nephritis10.1CD40LG, FN1
42cutaneous t cell lymphoma10.0CD5, FAS
43aplastic anemia10.0FASLG, FAS
44lymphopenia10.0FASLG, FAS
45hashimoto thyroiditis10.0FAS, FASLG
46systemic scleroderma10.0CD40LG, HLA-DRB1, HLA-DQB1
47primary biliary cirrhosis10.0HLA-DRB1, CD40LG
48multiple sclerosis, disease progression, modifier of10.0FASLG, HLA-DQB1, HLA-DRB1
49tuberculosis9.9HLA-DRB1, HLA-DQB1, FN1
50connective tissue disease9.9FN1, HLA-DRB1, CD40LG

Graphical network of the top 20 diseases related to Type Ii Mixed Cryoglobulinemia:



Diseases related to type ii mixed cryoglobulinemia

Symptoms for Type Ii Mixed Cryoglobulinemia

About this section

Drugs & Therapeutics for Type Ii Mixed Cryoglobulinemia

About this section

Drug clinical trials:

Search ClinicalTrials for Type Ii Mixed Cryoglobulinemia

Search NIH Clinical Center for Type Ii Mixed Cryoglobulinemia

Genetic Tests for Type Ii Mixed Cryoglobulinemia

About this section

Anatomical Context for Type Ii Mixed Cryoglobulinemia

About this section

MalaCards organs/tissues related to Type Ii Mixed Cryoglobulinemia:

31
Bone, B cells, Lymph node, Bone marrow, Brain, Liver

Animal Models for Type Ii Mixed Cryoglobulinemia or affiliated genes

About this section

Publications for Type Ii Mixed Cryoglobulinemia

About this section

Articles related to Type Ii Mixed Cryoglobulinemia:

(show all 48)
idTitleAuthorsYear
1
Scleritis and retinal vasculitis associated with a type II mixed cryoglobulinemia. (24259719)
2013
2
HCV proteins and immunoglobulin variable gene (IgV) subfamilies in HCV-induced type II mixed cryoglobulinemia: a concurrent pathogenetic role. (22690241)
2012
3
Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII). (23202510)
2012
4
Parvovirus B19-induced type II mixed cryoglobulinemia. (21854885)
2011
5
Clinical spectrum, treatment, and outcome of patients with type II mixed cryoglobulinemia without evidence of hepatitis C infection. (21239761)
2011
6
An experimental type II mixed cryoglobulinemia with renal glomerulopathy in ICR mice triggered by Capillaria hepatica infection. (21972091)
2011
7
HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemia. (20002609)
2010
8
Characterization of antibodies directed against the immunoglobulin light kappa chain variable chain region (VK) of hepatitis C virus-related type-II mixed cryoglobulinemia and B-cell proliferations. (19758144)
2009
9
Hepatitis C virus-associated type II mixed cryoglobulinemia vasculitis complicated with membranous proliferative glomerulonephritis. (19212913)
2009
10
Essential type II mixed cryoglobulinemia causing pyoderma gangrenosum-like ulcers. (18335149)
2008
11
Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia. (17526550)
2008
12
Efficacy and risk of rituximab in type II mixed cryoglobulinemia: a significant case report. (17936216)
2007
13
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. (17936227)
2007
14
The use of monoclonal antibody (rituximab) in the treatment of type II mixed cryoglobulinemia. (17625752)
2007
15
Paradoxical brain embolism associated with HCV-related type II mixed cryoglobulinemia. (17493820)
2007
16
HCV-related immunocytoma and type II mixed cryoglobulinemia-associated autoantigens. (17911427)
2007
17
HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations. (16617326)
2006
18
Transfusion-associated TT virus co-infection in patients with hepatitis C virus is associated with type II mixed cryoglobulinemia but not with B-cell non-Hodgkin lymphoma. (12691541)
2003
19
Cerebral vasculitis in a patient with HCV-related type II mixed cryoglobulinemia. (12968400)
2003
20
Efficacy and safety of rituximab in type II mixed cryoglobulinemia. (12560225)
2003
21
Influence of age and autoimmunity on liver disease in HCV-associated type II mixed cryoglobulinemia. (12175729)
2002
22
Rituximab for the treatment of type II mixed cryoglobulinemia. (12209536)
2002
23
Severe cutaneous vasculitis following intravenous infusion of gammaglobulin in a patient with type II mixed cryoglobulinemia. (12051404)
2002
24
Characterization of cryoglobulin, M protein, low molecular weight IgM in a patient with chronic hepatitis C and type II mixed cryoglobulinemia]. (11769562)
2001
25
Membranoproliferative glomerulonephritis and demyelinating neuropathy caused by type II mixed cryoglobulinemia associated with HCV infection. (10830181)
2000
26
Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma. (10643704)
2000
27
Peri-lesional injections of granulocyte-macrophage colony-stimulating factor in the management of chronic leg ulcers in type II mixed cryoglobulinemia. (10980654)
2000
28
Splenectomy may improve the glomerulopathy of type II mixed cryoglobulinemia. (10845834)
2000
29
Lack of Fas and Fas-L mutations in patients with lymphoproliferative disorders associated with SjAPgren's syndrome and type II mixed cryoglobulinemia. (10410268)
1999
30
Rituximab for the treatment of type II mixed cryoglobulinemia. (10586221)
1999
31
Failure of cyclosporin therapy in type II mixed cryoglobulinemia associated with hepatitis C virus infection. (9706447)
1998
32
Interferon for hepatitis C virus-negative type II mixed cryoglobulinemia. (9575053)
1998
33
Asymptomatic type II mixed cryoglobulinemia with a very high cryocrit level secondary to HCV infection. (9779567)
1998
34
GB virus C infection in patients with type II mixed cryoglobulinemia. (9382367)
1997
35
Detection and distribution of hepatitis C virus-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. (8977256)
1996
36
Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. (7503475)
1996
37
Type II mixed cryoglobulinemia treated with fludarabine. (8730157)
1996
38
Lymph node angiogenesis in lymphoproliferative disorders: type II Mixed cryoglobulinemia as a model. (8730490)
1995
39
Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. (7655017)
1995
40
Disappearance of cryoglobulins and remission of symptoms in a patient with HCV-associated type II mixed cryoglobulinemia after HIV-1 infection. (8730498)
1995
41
A pilot study on the effectiveness of cyclosporine in type II mixed cryoglobulinemia. (8730507)
1995
42
Low prevalence of hepatitis E virus in type II mixed cryoglobulinemia. (8647527)
1995
43
HLA expression in type II mixed cryoglobulinemia and chronic hepatitis C virus. (8730485)
1995
44
Lymphoproliferation in type II mixed cryoglobulinemia. (8730495)
1995
45
Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study. (7524736)
1994
46
Long-term effects of alpha-interferon therapy for type II mixed cryoglobulinemia. (7528704)
1994
47
High prevalence of hepatitis C virus RNA in the supernatant and the cryoprecipitate of patients with essential and secondary type II mixed cryoglobulinemia. (7525697)
1994
48
Hepatitis C virus infection in type II mixed cryoglobulinemia. (8216392)
1993

Variations for Type Ii Mixed Cryoglobulinemia

About this section

Expression for genes affiliated with Type Ii Mixed Cryoglobulinemia

About this section
Search GEO for disease gene expression data for Type Ii Mixed Cryoglobulinemia.

Pathways for genes affiliated with Type Ii Mixed Cryoglobulinemia

About this section

Pathways related to Type Ii Mixed Cryoglobulinemia according to GeneCards Suite gene sharing:

(show all 26)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Show member pathways
Calcium signaling in the CD4+ TCR pathway36
9.5CD40LG, FASLG
29.5FASLG, FN1
39.5HLA-DRB1, CD5
4
Show member pathways
9.4HLA-DRB1, HLA-DQB1
5
Show member pathways
9.4HLA-DRB1, HLA-DQB1
69.4HLA-DRB1, HLA-DQB1
79.4HLA-DRB1, HLA-DQB1
8
Show member pathways
Immune response IL 22 signaling pathway58
G protein signaling N RAS regulation pathway58
9.4HLA-DRB1, HLA-DQB1
99.4CD40LG, FN1
10
Show member pathways
Immune response IL 12 induced IFN gamma production58
9.4FASLG, HLA-DRB1
11
Show member pathways
FAS pathway and Stress induction of HSP regulation36
Apoptosis and survival FAS signaling cascades58
Caspase cascade in apoptosis36
9.2FASLG, FAS
12
Show member pathways
Transcription NF kB signaling pathway58
Immune response Toll like receptor TLR ligands and common TLR signaling pathway leading to cell proinflammatory response58
9.2FASLG, FAS
13
Show member pathways
TRAIL signaling pathway36
9.2FAS, FASLG
14
Show member pathways
Apoptosis and survival Apoptotic TNF family pathways58
9.2FASLG, FAS
159.2FASLG, FAS
16
Show member pathways
9.2FASLG, FAS
17
Show member pathways
9.2FASLG, FAS
189.2FASLG, FAS
198.9HLA-DQB1, HLA-DRB1, CD40LG
20
Show member pathways
8.9HLA-DQB1, HLA-DRB1, CD40LG
21
Show member pathways
8.9CD40LG, HLA-DRB1, HLA-DQB1
228.7FN1, FAS, FASLG
238.7FN1, FAS, FASLG
24
Show member pathways
8.3HLA-DQB1, FAS, FASLG, CD40LG
25
Show member pathways
8.2FASLG, FAS, HLA-DRB1, HLA-DQB1
26
Show member pathways
7.6CD40LG, FASLG, FAS, HLA-DRB1, HLA-DQB1

Compounds for genes affiliated with Type Ii Mixed Cryoglobulinemia

About this section

Compounds related to Type Ii Mixed Cryoglobulinemia according to GeneCards Suite gene sharing:

(show top 50)    (show all 81)
idCompoundScoreTop Affiliating Genes
1amoxicillin43 49 1211.9HLA-DQB1, CD40LG
2bosentan43 1210.9FN1, FASLG
3pmma439.6FN1, CD40LG
4(glc)4439.6FASLG, FAS
5atpo28 4310.6FAS, FASLG
6silicone439.5CD40LG, FN1
7teniposide43 1210.5FAS, FASLG
8biotin43 24 1211.4FN1, FASLG, CD40LG
9hyaluronic acid43 2410.3CD40LG, FASLG, FN1
10concanamycin a43 5910.2FASLG, FAS
11gliadin439.2FAS, HLA-DQB1, CD40LG
122-chlorodeoxyadenosine439.1CD40LG, FAS, FASLG
13fludarabine43 49 1211.1CD40LG, FASLG, FAS
14ivig439.1CD40LG, FAS, FASLG
15rottlerin439.1FASLG, CD40LG, FAS
16tetracycline43 1210.1CD40LG, FAS, FASLG
17adriamycin439.1FAS, FN1, FASLG
18tgf beta1439.1FASLG, FN1, FAS
19ionomycin439.0FAS, CD40LG, FASLG
20phosphatidylserine43 28 1211.0FAS, FASLG, CD40LG
21herbimycin a43 5910.0FN1, FAS, CD40LG
22rantes438.9CD40LG, FASLG, FAS
23aspirin43 49 28 2411.9CD40LG, FAS, FN1
24epinephrine43 24 1210.9FAS, CD40LG, FASLG
25n acetylcysteine438.9FASLG, FAS, CD40LG
26ascorbic acid43 249.8FAS, FASLG, CD40LG
27glutamate438.7HLA-DQB1, HLA-DRB1, FASLG, CD40LG
28sb 20358043 599.7FN1, FASLG, FAS
29aspartate438.7CD40LG, FAS, HLA-DQB1, FASLG
30alanine438.6CD40LG, HLA-DRB1, FN1, FASLG
31agar438.6FASLG, CD40LG, FAS, FN1
32indomethacin43 28 59 1211.6CD40LG, FASLG, FAS, FN1
33polysaccharide438.6FN1, FASLG, FAS, CD40LG
34rapamycin438.6FN1, FAS, FASLG, CD40LG
35doxorubicin43 49 1210.6FAS, CD40LG, FASLG, FN1
36actinomycin d438.6FN1, FASLG, CD40LG, FAS
37butyrate438.6FASLG, FAS, FN1
38genistein43 28 59 2 24 1213.6FN1, CD40LG, FAS, FASLG
39cyclosporin a43 28 5910.6CD40LG, FN1, FAS, FASLG
40lactate438.6FN1, CD40LG, FASLG, FAS
41cisplatin43 49 59 1211.6FN1, FASLG, CD40LG, FAS
42heparin43 28 24 1211.5CD40LG, FAS, FASLG, FN1
43oligonucleotide438.5FAS, FASLG, HLA-DRB1, HLA-DQB1
44dexamethasone43 49 28 1211.5FASLG, CD40LG, FAS, FN1
45vegf438.5FN1, FAS, FASLG, CD40LG
46arginine438.3CD40LG, FAS, FN1, HLA-DRB1
47paraffin438.2FASLG, CD40LG, CD5, FAS, FN1
48retinoic acid43 249.2CD40LG, FAS, FN1, FASLG
49cysteine437.9FN1, FAS, FASLG, CD40LG
50tyrosine437.7HLA-DQB1, FN1, FASLG, CD5, FAS, HLA-DRB1

GO Terms for genes affiliated with Type Ii Mixed Cryoglobulinemia

About this section

Cellular components related to Type Ii Mixed Cryoglobulinemia according to GeneCards Suite gene sharing:

(show all 11)
idNameGO IDScoreTop Affiliating Genes
1MHC class II protein complexGO:00426139.7HLA-DRB1, HLA-DQB1
2integral component of lumenal side of endoplasmic reticulum membraneGO:00715569.6HLA-DQB1, HLA-DRB1
3clathrin-coated endocytic vesicle membraneGO:00306699.6HLA-DRB1, HLA-DQB1
4transport vesicle membraneGO:00306589.6HLA-DQB1, HLA-DRB1
5ER to Golgi transport vesicle membraneGO:00125079.5HLA-DRB1, HLA-DQB1
6trans-Golgi network membraneGO:00325889.4HLA-DRB1, HLA-DQB1
7endocytic vesicle membraneGO:00306669.3HLA-DRB1, HLA-DQB1
8integral component of plasma membraneGO:00058878.7CD40LG, CD5, FASLG, HLA-DRB1
9external side of plasma membraneGO:00098977.9CD40LG, CD5, FASLG, FAS, HLA-DRB1
10extracellular vesicular exosomeGO:00700627.8FN1, HLA-DRB1, FAS, FASLG
11plasma membraneGO:00058867.7CD40LG, CD5, FAS, HLA-DRB1, HLA-DQB1

Biological processes related to Type Ii Mixed Cryoglobulinemia according to GeneCards Suite gene sharing:

(show all 15)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of endothelial cell apoptotic processGO:020003539.7CD40LG, FASLG
2immunoglobulin production involved in immunoglobulin mediated immune responseGO:00023819.7HLA-DQB1, HLA-DRB1
3humoral immune response mediated by circulating immunoglobulinGO:00024559.7HLA-DQB1, HLA-DRB1
4inflammatory cell apoptotic processGO:00069259.5FASLG, FAS
5necroptotic signaling pathwayGO:00975279.5FAS, FASLG
6interferon-gamma-mediated signaling pathwayGO:00603339.4HLA-DQB1, HLA-DRB1
7antigen processing and presentation of exogenous peptide antigen via MHC class IIGO:00198869.4HLA-DRB1, HLA-DQB1
8regulation of extrinsic apoptotic signaling pathway in absence of ligandGO:020012399.4FAS, FASLG
9T cell costimulationGO:00312959.4CD5, HLA-DRB1, HLA-DQB1
10extrinsic apoptotic signaling pathway via death domain receptorsGO:00086259.3FASLG, FAS
11extrinsic apoptotic signaling pathwayGO:00971919.3FASLG, FAS
12T cell receptor signaling pathwayGO:00508529.1HLA-DRB1, HLA-DQB1
13activation of cysteine-type endopeptidase activity involved in apoptotic processGO:00069199.1FASLG, FAS
14apoptotic signaling pathwayGO:00971909.1CD5, FASLG, FAS
15immune responseGO:00069559.1FASLG, HLA-DRB1, HLA-DQB1

Molecular functions related to Type Ii Mixed Cryoglobulinemia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1tumor necrosis factor receptor bindingGO:00051649.5CD40LG, FASLG
2MHC class II receptor activityGO:00323959.1HLA-DRB1, HLA-DQB1

Products for genes affiliated with Type Ii Mixed Cryoglobulinemia

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies
  • Proteins
  • Kits and Assays

Sources for Type Ii Mixed Cryoglobulinemia

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCIt
39NDF-RT
42NINDS
43Novoseek
45OMIM
46OMIM via Orphanet
50PubMed
51QIAGEN
56SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet